CATEGORIES

Industry News

LATEST

TRENDING

EDITORS CHOICE

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

Dallas Researchers Recruiting for Pediatric Migraine Clinical Trial

Cedar Health Research, located in Dallas and Irving, is currently enrolling candidates in two clinical trials to evaluate the safety and tolerability of Rimegepant

North Texas Obgyns Need to Know About Monoclonal Antibodies for Covid-19

Obgyn physicians and women's health providers must help pregnant people find access to monoclonal antibody therapy during the early stages of a Covid-19 infection to help prevent severe disease and death.

The Diversion of Drugs Within Healthcare Needs to be Addressed

The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting